InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Holles Natalie C.. Officer active across 2 companies, notably Third Harmonic Bio, Inc.. Aggregated, 4 reports have been recorded. History available since 11 April 2024. The latest transaction was filed on 9 May 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Holles Natalie C. is CEO of Third Harmonic Bio, Inc. and a Director at Day One Biopharmaceuticals, Inc. She has 4 filings in total. Among the sampled recent filings, the period runs from 2024-04-15 to 2026-04-23, and the modal transaction nature is option exercise.